Sofosbuvir, a recently approvednucleotide analog, is a highly potent inhibitor of the NS5B polymerase in theHepatitis C virus ( HCV). Sofosbuvir has a shown safety and efficiency in patientswith the advanced liver disease. The use of sofosbuvir in combination withribavirin provides the first FDA approved all oral therapy for hepatitis C andalso for patients with genotype 2 or 3.
Sofosbuvir currentlyhas a major role in the treatment of chronic HCV infection, but theextraordinarily high cost has served as a major barrier to more widespread useand treatment of persons with chronic HCV infection. Shabbir MedicalHall tried to eradicate this by providing the best rates from which one canImport sofosbuvir 400mg Tablets from India to Beijing.